← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #479 OF 1,000 MOST-CITED

Metal / extraneous materials

FDA cited this observation 39 times across 39 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods39
BY FISCAL YEAR
FY20191
FY201812
FY201726

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1.2× the rate of the average FDA-cited firm (10.3% vs 8.3%), across 39 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your Professional access…

How FDA worded it — real examples

Failure to take effective measures to protect against the inclusion of extraneous material in food.

Pankaj Exports Private Limited · Navi Mumbai · Foods · 2018-12-14

Failure to take effective measures to protect against the inclusion of metal and extraneous material in food.

Anahuac, Inc. · Mount Airy, North Carolina · Foods · 2018-08-23

Failure to take effective measures to protect against the inclusion of metal in food.

Productos Ole Del Ecuador Productosole Cia Ltda · Quito · Foods · 2018-06-22

Failure to take effective measures to protect against the inclusion of extraneous material in food.

M&B Distributors Inc · Cincinnati, Ohio · Foods · 2018-06-12

Failure to take effective measures to protect against the inclusion of extraneous material in food.

Chase Hill Farm · Warwick, Massachusetts · Foods · 2018-05-24

Failure to take effective measures to protect against the inclusion of metal and extraneous material in food.

URCIMAR · Fes · Foods · 2018-05-16

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →